Repligen Aktie
150,55
EUR
-3,20
EUR
-2,08
%
156,35
USD
-5,50
USD
-3,40
%
Werbung
Repligen Aktie Analyse
28.08.19 | Repligen Outperform | First Analysis Securities | |
22.07.19 | Repligen Buy | H.C. Wainwright & Co. | |
02.10.17 | Repligen Overweight | First Analysis Securities | |
29.10.09 | Repligen buy | Merriman Curhan Ford & Co | |
30.06.09 | Repligen buy | Merriman Curhan Ford & Co | |
13.06.08 | Repligen market outperform | Rodman & Renshaw, LLC | |
20.05.08 | Repligen | Global Biotech Investing | |
11.09.07 | Repligen market outperform | Rodman & Renshaw | |
Werbung
|
|||
12.04.07 | Repligen market outperform | Rodman & Renshaw | |
29.12.05 | Repligen overweight | Lehman Brothers | |
27.05.05 | Repligen market outperform | Rodman & Renshaw |
Werbung
Werbung